Keyphrases
5′-adenosine Monophosphate-activated Protein Kinase
12%
6-bisphosphatase 1
50%
6-P2
12%
Adenosine 5′-monophosphate
37%
AMP-activated Protein Kinase
12%
Antihyperglycemic
37%
Diabetic
12%
First-line Drugs
12%
Fructose-1,6-bisphosphatase
100%
Fructose-2,6-bisphosphate
12%
Gluconeogenesis
12%
Hepatic Glucose Production
12%
High-fat Diet
12%
Hyperinsulinemic-euglycemic Clamp
12%
Knock-in Mouse Model
25%
Liver Glucose Production
100%
Major Contributor
12%
Mechanism of Action
12%
Metformin
100%
Metformin Treatment
12%
Mitochondrial Respiratory Complex I
12%
Molecular Targets
12%
New Mechanisms of Action
12%
Point mutation
12%
Rate-controlling
12%
Therapeutic Action
12%
Tolerance Test
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Biochemistry, Genetics and Molecular Biology
Adenosine Monophosphate
80%
AMP-activated Protein Kinase
20%
Antidiabetic Activity
60%
Enzyme
40%
Fructose 1,6-bisphosphatase
100%
Fructose 2,6-bisphosphate
20%
Gluconeogenesis
100%
Point Mutation
20%
Protein Kinases
20%
Wild Type
20%
Medicine and Dentistry
Adenosine Phosphate
44%
Antidiabetic Activity
33%
Combination Therapy
11%
Diabetes Mellitus
11%
Fructose 2,6 Bisphosphate
11%
Fructose Bisphosphatase
100%
Gluconeogenesis
100%
Glycon
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
11%
Maturity Onset Diabetes of the Young
11%
Point Mutation
11%
Protein Kinases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Phosphate
44%
Combination Therapy
11%
Diabetes Mellitus
11%
Fructose 2,6 Bisphosphate
11%
Fructose Bisphosphatase
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
11%
Maturity Onset Diabetes of the Young
11%
Metformin
100%
Protein Kinases
11%